These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 17534004)

  • 41. Perforant path synaptic loss correlates with cognitive impairment and Alzheimer's disease in the oldest-old.
    Robinson JL; Molina-Porcel L; Corrada MM; Raible K; Lee EB; Lee VM; Kawas CH; Trojanowski JQ
    Brain; 2014 Sep; 137(Pt 9):2578-87. PubMed ID: 25012223
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of educational background on verbal fluency task performance in older adults with Alzheimer's disease and mild cognitive impairment.
    Kawano N; Umegaki H; Suzuki Y; Yamamoto S; Mogi N; Iguchi A
    Int Psychogeriatr; 2010 Sep; 22(6):995-1002. PubMed ID: 20602860
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In Thai Nationals, the ApoE4 Allele Affects Multiple Domains of Neuropsychological, Biobehavioral, and Social Functioning Thereby Contributing to Alzheimer's Disorder, while the ApoE3 Allele Protects Against Neuropsychiatric Symptoms and Psychosocial Deficits.
    Tangwongchai S; Supasitthumrong T; Hemrunroj S; Tunvirachaisakul C; Chuchuen P; Houngngam N; Snabboon T; Tawankanjanachot I; Likitchareon Y; Phanthumchindad K; Maes M
    Mol Neurobiol; 2018 Aug; 55(8):6449-6462. PubMed ID: 29307083
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evidence of the sensitivity of the MoCA alternate forms in monitoring cognitive change in early Alzheimer's disease.
    Costa AS; Reich A; Fimm B; Ketteler ST; Schulz JB; Reetz K
    Dement Geriatr Cogn Disord; 2014; 37(1-2):95-103. PubMed ID: 24107412
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intervention of multi-modal activities for older adults with dementia translation to rural communities.
    La Rue A; Felten K; Turkstra L
    Am J Alzheimers Dis Other Demen; 2015 Aug; 30(5):468-77. PubMed ID: 25657291
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of aerobic exercise on mild cognitive impairment: a controlled trial.
    Baker LD; Frank LL; Foster-Schubert K; Green PS; Wilkinson CW; McTiernan A; Plymate SR; Fishel MA; Watson GS; Cholerton BA; Duncan GE; Mehta PD; Craft S
    Arch Neurol; 2010 Jan; 67(1):71-9. PubMed ID: 20065132
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Decreased recall of primacy words predicts cognitive decline.
    Bruno D; Reiss PT; Petkova E; Sidtis JJ; Pomara N
    Arch Clin Neuropsychol; 2013 Mar; 28(2):95-103. PubMed ID: 23299182
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Connected speech as a marker of disease progression in autopsy-proven Alzheimer's disease.
    Ahmed S; Haigh AM; de Jager CA; Garrard P
    Brain; 2013 Dec; 136(Pt 12):3727-37. PubMed ID: 24142144
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of toy stimulation on the cognitive, communicative, and emotional functioning of adults in the middle stages of Alzheimer's disease.
    Murray LL; Dickerson S; Lichtenberger B; Cox C
    J Commun Disord; 2003; 36(2):101-27. PubMed ID: 12609577
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The CERAD Neuropsychological Battery in Patients with Idiopathic Normal Pressure Hydrocephalus Compared with Normal Population and Patients with Mild Alzheimer's Disease.
    Nerg O; Junkkari A; Hallikainen I; Rauramaa T; Luikku A; Hiltunen M; Jääskeläinen JE; Leinonen V; Hänninen T; Koivisto A
    J Alzheimers Dis; 2021; 81(3):1117-1130. PubMed ID: 33896842
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Change in Fitness and the Relation to Change in Cognition and Neuropsychiatric Symptoms After Aerobic Exercise in Patients with Mild Alzheimer's Disease.
    Sobol NA; Dall CH; Høgh P; Hoffmann K; Frederiksen KS; Vogel A; Siersma V; Waldemar G; Hasselbalch SG; Beyer N
    J Alzheimers Dis; 2018; 65(1):137-145. PubMed ID: 30040719
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Psychosocial interventions for Alzheimer's disease cognitive symptoms: a Bayesian network meta-analysis.
    Duan Y; Lu L; Chen J; Wu C; Liang J; Zheng Y; Wu J; Rong P; Tang C
    BMC Geriatr; 2018 Aug; 18(1):175. PubMed ID: 30086714
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effectiveness of reality orientation in the treatment of Alzheimer's disease.
    Camargo CH; Justus FF; Retzlaff G
    Am J Alzheimers Dis Other Demen; 2015 Aug; 30(5):527-32. PubMed ID: 25588408
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lack of practice effects on neuropsychological tests as early cognitive markers of Alzheimer disease?
    Zehnder AE; Bläsi S; Berres M; Spiegel R; Monsch AU
    Am J Alzheimers Dis Other Demen; 2007; 22(5):416-26. PubMed ID: 17959877
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Memory evaluation with a new cued recall test in patients with mild cognitive impairment and Alzheimer's disease.
    Ivanoiu A; Adam S; Van der Linden M; Salmon E; Juillerat AC; Mulligan R; Seron X
    J Neurol; 2005 Jan; 252(1):47-55. PubMed ID: 15654553
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Subtle Cognitive Decline and Biomarker Staging in Preclinical Alzheimer's Disease.
    Edmonds EC; Delano-Wood L; Galasko DR; Salmon DP; Bondi MW;
    J Alzheimers Dis; 2015; 47(1):231-42. PubMed ID: 26402771
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Impact of Exercise, Cognitive Activities, and Socialization on Cognitive Function: Results From the National Long-Term Care Survey.
    Jedrziewski MK; Ewbank DC; Wang H; Trojanowski JQ
    Am J Alzheimers Dis Other Demen; 2014 Jun; 29(4):372-8. PubMed ID: 24408752
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Can the sensitivity of the Alzheimer's Disease Assessment Scale be increased?
    Mattes JA
    Am J Geriatr Psychiatry; 1997; 5(3):258-60. PubMed ID: 9209568
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Discrimination between stages of Alzheimer's disease with subsets of Mini-Mental State Examination items. An analysis of Consortium to Establish a Registry for Alzheimer's Disease data.
    Fillenbaum GG; Wilkinson WE; Welsh KA; Mohs RC
    Arch Neurol; 1994 Sep; 51(9):916-21. PubMed ID: 8080392
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Changes over time in memory, processing speed and clock drawing tests help to discriminate between vascular cognitive impairment, mild cognitive impairment and Alzheimer's disease.
    de Jager CA
    Neurol Res; 2004 Jul; 26(5):481-7. PubMed ID: 15362213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.